As February wraps up, the Investing News Network (INN) offers a closer look at the biggest stories of the month in the cannabis public markets.

During the month, the upcoming retail market in Ontario gain attention from the market as public companies began securing arrangements with winners of a lottery set to determine the first 25 stores in the province.


Ontario is one of the most coveted marijuana markets in Canada, and as such firms such as Canopy Growth (NYSE:CGC,TSX:WEED), Aurora Cannabis (NYSE:ACB,TSX:ACB), Alcanna (TSX:CLIQ), High Tide (CSE:HITI,OTC Pink:HTDEF), Fire & Flower Holdings (TSXV:FAF), Choom (CSE:CHOO,OTCQB:CHOOF) and Inner Spirit Holdings (CSE:ISH) in partnership with licensed producer (LP) Newstrike Brands (TSXV:HIP,OTC Pink:NWKRF) have secured deals in place directly or through investment in other firms.

“It was no secret that deals were being tabled in the week that our retail operators had to complete their retail operator license application,” Brenna Boonstra, director of quality and regulatory consulting Cannabis Compliance, told INN.

2019 will offer a different trend in marijuana investing

As part of an evaluation with experts and analysts of the cannabis public market, INN put together a guide for investors of the key investment trend in 2019: multi-state operators (MSOs).

“What we’ve done is become more aggressive on the US cannabis names, just over the past five to six months, rather than focus on the Canadian licensed producers (LPs),” Nawan Butt, portfolio manager with Purpose Investments said.

He is referring to companies operating the US legal cannabis states, through the rollout of networks of dispensaries, growing facilities and more.

These ventures have quickly risen in the attention from the market and investors.

“I think that the US companies have the confidence of investors and they’re going to be able to raise more capital,” Alan Brochstein, cannabis researcher with 420 Investor, told INN.

Watch the video above for more on what happened during the month of February.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: High Tide and Inner Spirit Holdings are clients of the Investing News Network. This article is not paid-for content.

NYSE | TSX: ACB

Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less